Where does Merit Medical Systems's cash flow data come from?

Every line is extracted from Merit Medical Systems's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Net income	$128.49M+6.8%	$120.36M+27.5%	$94.41M+26.7%	$74.52M+53.8%
Depreciation and amortization	$123.17M+19.9%	$102.71M+14.1%	$89.99M+10.0%	$81.8M-2.7%
Stock-based compensation	$43.46M+52.6%	$28.47M+33.5%	$21.33M+18.2%	$18.04M+12.1%
Amortization of debt issuance costs	——	——	$1.72M+184%	$604K0.0%
Impairment charges	$313K-31.4%	$456K—	——	$2.28M—
Gain (loss) on sale of assets	-$2.3M-54.5%	-$1.49M+74.5%	-$5.84M-1,436%	-$380K+70.8%
Change in accounts receivable	——	$13.69M—	——	$15.53M—
Change in inventories	$21.6M—	——	——	$47.93M+90.3%
Change in accounts payable	——	——	——	$12.66M—
Change in accrued liabilities	$14.26M—	——	——	——
Change in other assets	——	——	——	——
Change in other liabilities	——	——	-$2.53M—	——
Other working capital changes	$168.88M+68.1%	$100.44M+98.0%	$50.74M—	——
Change in income taxes payable/receivable	$5.61M—	——	——	$4.55M—
Net gains (losses) on investments	——	——	——	——
Non-cash operating lease expense	$11.48M-4.5%	$12.02M+6.3%	$11.31M+8.8%	$10.39M-11.3%
Change in operating lease liabilities	-$11.17M+8.3%	-$12.18M-6.0%	-$11.49M-3.3%	-$11.13M+10.3%
Change in fair value of contingent consideration	——	$443K—	——	——
Change in receivables	——	$6.69M+375%	-$2.43M—	——
Net cash from operating activities	$297.37M+34.7%	$220.8M+52.1%	$145.15M+27.0%	$114.29M-22.4%
Capital expenditures	$81.72M+133%	$35.14M+2.5%	$34.29M-23.8%	$45.03M+61.2%
Acquisitions, net of cash acquired	$144.77M-54.8%	$320.18M—	——	——
Proceeds from sale of businesses	——	——	$431K+144%	-$971K—
Purchases of intangible assets	$3.12M+7.5%	$2.9M+20.4%	$2.41M-24.1%	$3.18M+12.0%
Net cash from investing activities	-$247.39M+32.9%	-$368.65M-110%	-$175.35M-205%	-$57.4M-54.5%
Proceeds from issuance of debt	——	——	$1.2B+457%	$215.21M+119%
Proceeds from issuance of common stock	$28.21M-31.0%	$40.91M+163%	$15.58M-22.4%	$20.07M-5.8%
Other financing activities	$2.69M+929%	$261K-92.7%	$3.57M-89.2%	$32.92M+209%
Net cash from financing activities	$16.36M—	——	$613.82M+1,119%	-$60.26M+38.8%
Effect of exchange rate changes on cash	$3.8M+251%	-$2.52M—	——	——
Net increase (decrease) in cash	$69.78M+133%	-$210.38M-139%	$542.01M—	——
Interest paid	——	$23.24M+65.4%	$14.05M+125%	$6.26M+19.0%
Income taxes paid	$31.39M-30.3%	$45.05M+42.9%	$31.53M+84.5%	$17.09M+93.6%
Non-cash interest expense	——	——	——	——
Contingent consideration fair value adjustments	——	$443K—	——	——
Gain/(loss) on dispositions, net	-$2.3M-54.5%	-$1.49M+74.5%	-$5.84M-1,436%	-$380K+70.8%
Gain on sale of business and assets	$249K—	——	$431K—	——
Equity in earnings (losses) of equity method investees	——	——	——	——
Accounts payable	——	——	——	$12.66M—
Increase Decrease In Deferred Compensation	——	$2.05M—	——	——
Increase (Decrease) in Income Taxes Receivable	-$246K—	——	——	-$1.95M—
Operating lease liabilities	-$11.17M+8.3%	-$12.18M-6.0%	-$11.49M-3.3%	-$11.13M+10.3%
Increase (Decrease) in Other Operating Assets	$1.83M-69.8%	$6.07M—	——	——
Increase (Decrease) in Other Receivables	——	$6.69M+375%	-$2.43M—	——
Increase (Decrease) in Prepaid Expense and Other Assets	——	——	——	——
Operating lease right-of-use asset amortization	$11.48M-4.5%	$12.02M+6.3%	$11.31M+8.8%	$10.39M-11.3%
Payments to Acquire Intangible Assets	$3.12M+7.5%	$2.9M+20.4%	$2.41M-24.1%	$3.18M+12.0%
Proceeds From Sale Of Property Plant And Equipment And Divestiture Of Businesses	$303K+5,960%	$5K-99.2%	$632K—	——
Payments For Derivative Instrument Financing Activities	——	——	$66.53M—	——
Payments Related To Tax Withholding For Exchange Of Common Stock	$9.53M—	——	——	$2.47M—
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations	$3.8M+251%	-$2.52M—	——	——
Leased assets obtained in exchange for operating lease liabilities	$32.68M+229%	$9.95M+11.9%	$8.89M-20.1%	$11.13M+630%
Income Taxes Paid, Net	$31.39M-30.3%	$45.05M+42.9%	$31.53M+84.5%	$17.09M+93.6%
Free cash flow	$215.66M+16.2%	$185.66M+67.5%	$110.86M+60.1%	$69.26M-41.9%
Free cash flow	$215.66M+16.2%	$185.66M+67.5%	$110.86M+60.1%	$69.26M-41.9%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Merit Medical Systems's cash flow data come from?: Every line is extracted from Merit Medical Systems's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.